subscribeSubscribe
Padagis` Generic Halobetasol Propionate Receives Approval in the U.S.

Padagis` Generic Halobetasol Propionate Receives Approval in the U.S.
FDA
11 Aug 2023
Share Share
Padagis` Generic Halobetasol Propionate Receives Approval in the U.S.

Padagis` Generic Halobetasol Propionate Receives Approval in the U.S.
FDA
17 Oct 2022
Share Share
Enforcement Report - Week of May 11, 2022

Enforcement Report - Week of May 11, 2022
PRESS RELEASE
11 May 2022
Share Share
Enforcement Report - Week of March 30, 2022

Enforcement Report - Week of March 30, 2022
FDA
30 Mar 2022
Share Share
Enforcement Report - Week of January 26, 2022

Enforcement Report - Week of January 26, 2022
FDA
26 Jan 2022
Share Share
Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology

Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology
PRNEWSWIRE
19 Oct 2021
Share Share
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis

FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
PRNEWSWIRE
21 Sep 2021
Share Share
Perrigo Israel`s Generic HalobetasolPropionate Receives Tentative Approval in US

Perrigo Israel`s Generic HalobetasolPropionate Receives Tentative Approval in US
FDA
18 Nov 2020
Share Share
Perrigo Israel`s Generic Halobetasol Propionate Receives Approval in US

Perrigo Israel`s Generic Halobetasol Propionate Receives Approval in US
FDA
09 Jun 2020
Share Share
Health Canada Issues Recall of Bausch Health Canada `s Ultravate

Health Canada Issues Recall of Bausch Health Canada `s Ultravate

FDA
21 Apr 2020
Share Share